Aclarion (ACON) Amortization of Deferred Charges (2023 - 2024)

Aclarion's (ACON) quarterly Amortization of Deferred Charges came in at -$31129.0 in Q4 2024, down 109.12% YoY from $341497.0 in Q1 2024, and down 380.16% on a QoQ basis from $11111.0 in Q3 2024.

Aclarion (ACON) Amortization of Deferred Charges (2023 - 2024) Analysis & Trends

Aclarion (ACON) has 2 years of Amortization of Deferred Charges data on file, last reported at -$31129.0 in Q4 2024.

  • Quarterly Amortization of Deferred Charges fell 109.12% year-over-year to -$31129.0 in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$31129.0 (down 103.69% YoY) and the FY2024 annual result came in at $471387.0, down 5.28% from the prior year.
  • Amortization of Deferred Charges slipped to -$31129.0 in Q4 2024, from $11111.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $341497.0 in Q4 2023 to a low of -$31129.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn
10 Aclarion 6.06 Mn 6.06 Mn 8,297.00

Historic Data

Download Data
DateValue
Dec 31, 2024 -31,129.00
Dec 31, 2024 -31,129.00
Sep 30, 2024 11,111.00
Sep 30, 2024 11,111.00
Jun 30, 2024 156,053.00
Jun 30, 2024 156,053.00
Mar 31, 2024 335,352.00
Mar 31, 2024 335,352.00
Dec 31, 2023 341,497.00
Dec 31, 2023 341,497.00
Sep 30, 2023 127,639.00
Sep 30, 2023 127,639.00
Jun 30, 2023 28,520.00
Jun 30, 2023 28,520.00